Patents by Inventor Catherine Tripp

Catherine Tripp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for treating asthma using anti-IL-13 antibodies
    Patent number: 10919961
    Abstract: The invention provides methods and compositions for treating asthma, e.g., mild or moderate asthma, in a subject using an anti-IL-13 antibody, or antigen-binding portion thereof.
    Type: Grant
    Filed: June 27, 2017
    Date of Patent: February 16, 2021
    Assignee: Abbvie, Inc.
    Inventor: Catherine Tripp
  • METHODS AND COMPOSITIONS FOR TREATING ASTHMA USING ANTI-IL-13 ANTIBODIES
    Publication number: 20180079808
    Abstract: The invention provides methods and compositions for treating asthma, e.g., mild or moderate asthma, in a subject using an anti-IL-13 antibody, or antigen-binding portion thereof.
    Type: Application
    Filed: June 27, 2017
    Publication date: March 22, 2018
    Inventor: Catherine Tripp
  • METHODS AND COMPOSITIONS FOR TREATING ASTHMA USING ANTI-IL-13 ANTIBODIES
    Publication number: 20140341913
    Abstract: The invention provides methods and compositions for treating asthma, e.g., mild or moderate asthma, in a subject using an anti-IL-13 antibody, or antigen-binding portion thereof.
    Type: Application
    Filed: July 2, 2012
    Publication date: November 20, 2014
    Applicant: ABBVIE INC.
    Inventor: Catherine Tripp